Docteur GURDEBEKE Christine SRL
Docteur GURDEBEKE Christine reported total assets of 93,566 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 May 2026).
The score of Docteur GURDEBEKE Christine shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +91 % Total assets +50 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Docteur GURDEBEKE Christine's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 May 2026
- Year ended 31 Dec 2024filed on 30 May 2025
- Year ended 31 Dec 2023filed on 10 Mar 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
Docteur GURDEBEKE Christine's financial analysis
- Solvency79.2%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Docteur GURDEBEKE Christine
Docteur GURDEBEKE Christine's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0777.870.021
- VAT number
- BE0777870021
- Peppol
- Registered · 0208:0777870021 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2021
- Registered office
- 4845 Jalhay
- Latest accounts
- 2025 · filed on 27 May 2026
- Activity
- Medical specialists activities (NACE 86220)
Docteur GURDEBEKE Christine (SRL) has been based in Jalhay since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 51,726 € and equity of 74,076 €; its revenue is not published. Its solvency stands at 79.2%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Docteur GURDEBEKE Christine
Companies in the same business, of comparable size and area, outside its group.
- JDS Dermato Medical specialists activities Hasselt · balance sheet 110,929 €
- Dr. W. Van Rompaey Medical specialists activities Brasschaat · balance sheet 231,320 €
- OM Neuropsy Medical specialists activities Oupeye · balance sheet 36,130 €
- Dr. J. Dierickx Medical specialists activities Ghent · balance sheet 34,649 €
- Reva BVM Medical specialists activities Kruisem · balance sheet 31,034 €
- Dr. Eno Lavrysen Neurochirurgie Medical specialists activities Mortsel · balance sheet 413,674 €
- Dokter Christel Linsen Medical specialists activities Lommel · balance sheet 426,228 €
- Dr. Waelbers Medical specialists activities Mechelen · balance sheet 260,837 €
Frequently asked questions about Docteur GURDEBEKE Christine
What is the revenue of Docteur GURDEBEKE Christine?
Docteur GURDEBEKE Christine files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Docteur GURDEBEKE Christine?
In Belgium, the VAT number is the company number prefixed with BE: BE0777870021 for Docteur GURDEBEKE Christine, if the company is VAT-registered. Its company number (CBE) is 0777.870.021.
Where is the registered office of Docteur GURDEBEKE Christine?
According to the CBE register, the registered office of Docteur GURDEBEKE Christine is in 4845 Jalhay.
What is the equity of Docteur GURDEBEKE Christine?
At the close of the 2025 financial year, the equity of Docteur GURDEBEKE Christine amounts to 74,076 €, a solvency of 79.2% of total assets.
Who manages Docteur GURDEBEKE Christine?
The register lists 1 active mandates at Docteur GURDEBEKE Christine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Docteur GURDEBEKE Christine
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →